This study proposes an innovative and scalable solution to increase oral bioavailability of therapeutic peptides using a combination of lipid-based formulation, hydrophobic ion pairing, permeation enhancer and customized enteric capsules.
The results highlight the capacity to support formulation development, and manufacture a functional capsule that is compatible with fill formulation. This offers biopharmaceutical companies a novel way to maximize the effectiveness of their therapeutic peptide.
If you would like to discuss how we can support you with your drug development journey, please speak with our scientists at Innovaform® Accelerator.